Intec Pharma Ltd.
Latest News & Stories on Intec Pharma Ltd. (NASDAQ:NTEC) (TASE:NTEC)
Intec Pharma Ltd. (NASDAQ:NTEC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. Intec's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. Intec's product pipeline includes four product candidates in clinical trial stages including an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia.